SCHEMBL7378745

SCHEMBL7378745

[CH2]c1cccc(-c2ncc(N(CC)CC)[nH]2)c1

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 3/20 0.37
HRH4 Q9H3N8 2/20 0.37
KMT2A Q03164 1/20 0.35
SCN2A Q99250 3/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LRRK2 Q5S007 1/20 0.33
COMT P21964 1/20 0.33
NPY5R Q15761 2/20 0.33
HPGDS O60760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7373915 0.84 SCN2A (0.37) HRH1HRH4SCN2ACOMTNPY5R
SCHEMBL7378122 0.74 HRH1 (0.40) HRH1HRH4SCN2AKDM4EALDH1A1
SCHEMBL7378581 0.72 HRH1 (0.42) HRH1HRH4KMT2ASCN2AKDM4E
SCHEMBL7377830 0.72 HRH1 (0.39) HRH1HRH4SCN2ANPY5RHPGDS
SCHEMBL7377289 0.71 KMT2A (0.35) KMT2ALRRK2NPY5R
SCHEMBL7372524 0.70 MAPT (0.41) KMT2AALDH1A1
SCHEMBL1985682 0.65 IDO1 (0.64) ALDH1A1
SCHEMBL27690834 0.65 CYP2E1 (0.58) HPGDS
SCHEMBL7378474 0.64 F2R (0.36) KMT2A
SCHEMBL401001 0.63 ALDH1A1 (0.59) KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO claimed
US-5763469-A Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-09 US disclosed
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO disclosed